COVID News from business-standard.com

Cipla will use Covid-19 bulk drugs inventory when demand rises by business-standard.com
Mumbai-based Cipla, which reported a one-time cost of Rs 200 crore for Covid-19 inventory and other charges in the March quarter (Q4), is sitting on inventory o...
CEPI funds Bharat Biotech consortium project for variant-proof Covid-19 jab by business-standard.com
The Coalition for Epidemic Preparedness Innovations (CEPI), a partnership between public, private, philanthropic organisations to develop vaccines against futur...